TABLE 3.
Progress in the research regarding flavonoids for the treatment of iron overload.
| Classification | Compound | Model | Mechanism | Results | References |
| Flavones | Baicalein | Male Wistar rats | Scavenged radical | Decreased the level of lipid and protein iron overload-induced oxidation | Czapski et al. (2012) |
| A mouse model of aplastic anemia with iron overload complication | Up-regulated hepcidin and its regulators (BMP-6, SMAD, and TfR2) at the protein and mRNA levels | Protected iron overload-induced apoptosis and reduced iron deposition | Dijiong et al. (2019) | ||
| A model of UV/Visible spectroscopic studies | Modulation of metal homeostasis and the inhibition of Fenton chemistry | Ameliorated iron status and decreased iron overload-induced oxidation | Perez et al. (2009) | ||
| Baicalin | Male Kunming mice | Be capable of the antioxidant and iron chelation activities | Protected the liver of iron overload | Zhao et al. (2005) | |
| Hepatocytes CYP2E1 | Chelated iron | Decreased iron overload-induced oxidation | Xu et al. (2012) | ||
| A model of Electron Spin Resonance spectra | Facilitated the transfer of electrons from Fe(2+) to dissolved oxygen | Decreased iron overload-induced oxidation | Nishizaki and Iwahashi (2015) | ||
| C6 cells | Positively regulated divalent metal transporter 1 expression and negatively regulated ferroportin 1 expression | Down-regulated iron concentration and decreased iron deposition | Guo et al. (2014) | ||
| Male Wistar rats | Chelated iron and educed the loss of tyrosine hydroxylase-positive cells | Reduced iron deposition in different brain regions and protected dopaminergic neurons | Xiong et al. (2012) | ||
| Apigenin | A375 human melanoma cell line and | Chelated iron, scavenged radical and inhibited lipoxygenase | Decreased iron overload-induced oxidative damage | Danciu et al. (2018) | |
| Luteolin | A model evaluated the pH effect on the lipid oxidation and polyphenols | Chelated iron and scavenged radical | Decreased iron overload-induced lipid oxidation | Kim and Choe (2018) | |
| Flavonols | Quercetin | MDCK cells | Facilitated chelatable iron shuttling via glucose transport proteins in either direction across the cell membrane | Ameliorated iron status | Vlachodimitropoulou et al. (2011) |
| Male Wistar rats | Be capable of the antioxidant and iron chelation activities | Decreased iron overload-induced oxidative damage, hepatotoxicity and nephrotoxicity | Gholampour and Saki (2019) | ||
| Human colon carcinoma cell line HT29 clone 19A | Protected iron overload-induced DNA breaks and oxidized bases | Decreased iron overload-induced oxidative damage | Glei et al. (2002) | ||
| Male specific-pathogen-free C57BL/6J mice | Lowered the iron level particularly in the islet in T2DM mice and abolished partially oxidative stress in pancreatic tissue | Decreased iron overload-induced oxidative damage | Li et al. (2020) | ||
| β-thalassemia major patients | Reduced high sensitivity C-reactive protein, iron, ferritin, and transferrin saturation and increased transferrin | Ameliorated iron status | Sajadi Hezaveh et al. (2019) | ||
| HUVECs | Protected iron overload-induced mitochondrial dysfunction via ROS/ADMA/DDAHII/eNOS/NO pathway | Decreased iron overload-induced cell damage | Chen et al. (2020) | ||
| Male Kunming mice | Inhibited iron overload-induced lipid peroxidation and protein oxidation of liver, decreased hepatic iron and hepatic collagen content, increased the serum non-heme iron level, released iron from liver and finally excrete it through feces | Decreased iron overload-induced oxidative damage, ameliorated iron status, and reduced iron deposition by excreting iron through feces | Kim and Choe (2018) | ||
| Rutin | Male albino rats | Be capable of the antioxidant and iron chelation activities | Decreased iron overload-induced oxidative damage | Aziza et al. (2014) | |
| Kaempferol | HepG2 cells | Protected arachidonic acid and iron induced ROS | Decreased arachidonic acid and iron overload-induced oxidative damage | Cho et al. (2019) | |
| Myricetin | SH-SY5Y cells | Reduce iron contents may via inhibiting transferrin receptor 1 (TfR1) expression | Ameliorated iron status | Wang et al. (2017) | |
| Sprague Dawley male animals rat hepatocytes | Prevented both lipid peroxidation and accumulation of oxidation products in DNA via stimulation of DNA repair processes | Decreased iron overload-induced genotoxicity | Abalea et al. (1999) | ||
| Flavanones | Naringenin | Male Wistar rats | Improved antioxidant enzyme activities | Decreased iron overload-induced oxidative damage | Chtourou et al. (2014) |
| Male Wistar rats | Scavenged radical | Restores iron overload-induced brain dysfunction | Chtourou et al. (2015) | ||
| Flavanols | Catechin | Male ICR mice | Chelated iron and Scavenged reactive oxygen active nitrogen | Decreased arachidonic acid and iron overload-induced oxidative damage | Yang et al. (2019) |
| Male Swiss albino mice | Chelated iron and scavenged radical | Decreased iron overload-induced oxidative damage | Chaudhuri et al. (2015) | ||
| Isoflavones | Purerarin | Male Kunming mice and ARPE-19 cells | Be associated with regulation of iron-handling proteins, enhancement of the antioxidant capacity, and the inhibition of MAPK and STAT3 activation and the apoptotic pathways under iron overload condition | Decreased iron overload-induced retinal oxidative damage and reduced retinal iron deposition | Song et al. (2020) |
| APPswe/PS1ΔE9 transgenic mice | Decreased iron levels and malondialdehyde content, increased glutathione peroxidase and superoxide and reduced inflammatory response markers | Decreased iron overload-induced oxidative damage and inflammatory response markers | Zhang et al. (2018) | ||
| Genistein | HepG2 cells | Be related to the BMP response element or the STAT3-binding site in the Hepcidin promoter | Increased Hepcidin transcript levels and promoter activity | Zhen et al. (2013) |